PUMA BIOTECHNOLOGY, INC. Quarterly Marketable Securities, Current in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Puma Biotechnology, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2013 to Q2 2024.
  • Puma Biotechnology, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $29.7M, a 106% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $29.7M +$15.3M +106% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $30.4M +$20.6M +210% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $11.4M +$6.48M +133% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $3.23M +$3.23M Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $14.4M +$6.43M +80.4% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $9.82M -$171K -1.71% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4.87M -$14.1M -74.3% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $0 -$23.6M -100% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $8M -$11.1M -58.2% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $9.99M -$3.4M -25.4% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $19M +$10.9M +134% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $23.6M +$4.65M +24.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $19.1M +$2.75M +16.8% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $13.4M -$3.77M -22% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $8.1M -$43.5M -84.3% Dec 31, 2020 10-K 2022-03-03
Q3 2020 $18.9M -$32.6M -63.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $16.4M -$74.1M -81.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $17.2M -$84.4M -83.1% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $51.6M -$5.4M -9.47% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $51.5M -$8.12M -13.6% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $90.5M +$51.9M +134% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $102M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $57M Dec 31, 2018 10-K 2020-02-28
Q3 2018 $59.7M +$33M +124% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $38.6M -$32.2M -45.5% Jun 30, 2018 10-Q 2018-08-09
Q3 2017 $26.6M -$29.8M -52.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $70.8M -$15.1M -17.6% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $88.9M -$14.1M -13.7% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $35M -$149M -81% Dec 31, 2016 10-K 2018-03-09
Q3 2016 $56.4M -$168M -74.8% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $86M -$137M -61.4% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $103M -$51.9M -33.5% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $184M +$81.5M +79.3% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $224M +$98.6M +78.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $223M +$99.5M +80.9% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $155M +$122M +373% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $103M +$61.9M +151% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $126M +$81.2M +183% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $123M +$76.4M +164% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $32.7M +$5.66M +20.9% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $40.9M Dec 31, 2013 10-K 2015-03-02
Q3 2013 $44.4M Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $46.6M Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $27.1M Mar 31, 2013 10-Q 2013-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.